Tirzepatides dual-action mechanism Tirzepatide mimics GLP-1 , just like semaglutide, but it also mimics another hormone called glucose-dependent insulinotropic polypeptide (GIP)
Monitoring requirements include assessment for signs of pancreatitis (persistent severe abdominal pain, often radiating to the back, with or without vomiting) and gallbladder disease (right upper quadrant pain, nausea, vomiting), both of which have been reported with GLP-1 receptor agonists
Mounjaro/Tirzepatide 12.5mg (4 Inyecciones) Historial personal o familiar de carcinoma medular de tiroides (MTC) Pancreatitis previa o historial de pancreatitis recurrente Embarazo o lactancia Gastroparesia o trastornos severos gastrointestinales Hipersensibilidad o alergia al medicamento Tirzepatide GLP-1 GIP La tirzepatida es un pptido nico que activa los receptores del cuerpo para GIP y GLP 1, dos hormonas incretinas naturales.El PIB ha disminuido la ingesta de alimentos y ha aumentado el gasto energtico, lo que ha dado lugar a reducciones de peso.Combinado con un agonista del receptor GLP-1, tiene un efecto ms significativo sobre la glucosa y el peso corporal
Unlock the Benefits of a Personalized Approach to Weight Loss Achieve your weight loss goals with our personalized approach that tailors every aspect of the program to your unique needs
How to store the reconstituted vial After mixing, the reconstituted solution must be stored properly to stay effective
